Bnp Paribas Arbitrage, Snc »

Palisade Bio shares owned by Bnp Paribas Arbitrage, Snc

Quarter-by-quarter ownership of Palisade Bio (PALI) shares owned by Bnp Paribas Arbitrage, Snc from 13F filings

Historical chart of Bnp Paribas Arbitrage, Snc investment in Palisade Bio

Tip: Access up to 7 years of quarterly data

All positions including Palisade Bio held by Bnp Paribas Arbitrage, Snc consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Palisade Bio by Bnp Paribas Arbitrage, Snc

Quarter filed Position value Share count Share price at filing
2026-03-31 $331k 189k 1.75

More positions owned by Bnp Paribas Arbitrage, Snc

NVIDIA Corp Equity (NVDA)
Microsoft Corp Equity (MSFT)
Amazon.com Equity (AMZN)
Apple Equity (AAPL)
State Street SPDR S&P Biotech ETF Fund (XBI)
Tesla Equity (TSLA)
Broadcom Equity (AVGO)
Alphabet Equity (GOOGL)
Alphabet Equity (GOOG)
JPMorgan Chase & Co Equity (JPM)
Meta Platforms Equity (META)
State Street SPDR S&P 500 ETF Trust Fund (SPY)
Micron Technology Equity (MU)
iShares Russell 2000 ETF Fund (IWM)
Oracle Corp Equity (ORCL)

View all positions for Bnp Paribas Arbitrage, Snc

Top funds holding Palisade Bio

Henderson Group
Octagon Capital Advisors
Perceptive Advisors
Ameriprise Financial
Commodore Capital
RA Capital Management
Franklin Resources
Eversept Partners
Goldman Sachs Group
Boxer Capital Management
Morgan Stanley
Adage Capital Partners GP
Dr. Jeffrey R. Jay, M.D.
Balyasny Asset Management
Federated Investors

View all funds holding Palisade Bio